ATC Group: J07BX01 Smallpox and monkeypox vaccines

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J07BX01 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J07 Vaccines
3 J07B Viral vaccines
4 J07BX Other viral vaccines
5 J07BX01

Active ingredients in J07BX01

Active Ingredient Description
Smallpox, live attenuated

Smallpox vaccine is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.

Related product monographs

Title Information Source Document Type  
IMVANEX Suspension for injection European Medicines Agency (EU) MPI, EU: SmPC
JYNNEOS Suspension for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Austria (AT)

Croatia (HR)

Estonia (EE)

France (FR)

Ireland (IE)

Italy (IT)

Lithuania (LT)

Poland (PL)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.